NIOX

Focus: NIOX is a biotechnology company specializing in FeNO (fractional exhaled nitric oxide) measurement devices for asthma management, focused on the respiratory disease market.

Respiratory

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About NIOX

AI assessmentNot Hiring

No open roles listed right now. Follow NIOX to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

FeNO

Asthma

N/A

FeNO measurement

Asthma

N/A

Clinical Trials (1)

Help build intelligence for NIOX

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on a focused, specialized respiratory diagnostic platform with clear clinical utility in asthma management
Early-stage biotech environment offers hands-on involvement across functions with potential for rapid skill development
Potential to establish foundational roles in a growing respiratory diagnostics company with room for career advancement

Watch Out For

No current active job openings reported, indicating limited or stalled hiring activity
Limited public financial data, pipeline depth, and clinical trial activity (only 1 trial on record) suggest early-stage constraints on resources and scope

Generated by Claude from NIOX's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT05853809Cluster-Randomized Asthma FeNO Trial

N/A

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Top TAs: Respiratory

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Respiratory

1 pipeline

Marketed

Pipeline